GAD2 and nervous system disorder: Future prospective studies would better inform the potential complementary role of FDG-PET in the diagnosis and monitoring of individuals with SPSSD and will potentially allow us to better understand the expanding spectrum of anti-GAD65-associated neurologic disorders.